nearhatpubmed.ncbi.nlm.nih.gov/38093366/
Looks promising.
Did you actually read that? Did nothing on most tests, and the rest were statistically significant, but effects will not change anyone’s quality of life.
Conclusion is it needs a proper double blind CT.
Nothing burger. FDA approves all kids of drugs that show significance on CT endpoints but do fuck all to help someone, because the point is not quality of life, it’s pharma profits.
Did you read it?? It showed statistical significance with an 8 point difference on the outcome measure test. And them for you so say this drug needs a double blind controlled trial? It was. That is literally the first sentence in the methods section! Also, the article went into details about the outcomes measures and quality of life impacts.
Just going to throw this out there, you had to follow the doi link, then download the pdf to read the actual article. It sounds like you just glazed over the summary paragraphs.